House Republicans Seek Top Down Change To FDA’s Warning-Letter Appeals
This article was originally published in The Tan Sheet
Executive Summary
FDA leadership needs to review the agency's enforcement dispute resolution process, according to ranking Republicans on the House Energy and Commerce Committee